Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tirzepatide”

175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 175 results

Not applicableLooking for participantsNCT07364175
What this trial is testing

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Who this might be right for
HypertensionObesity & Overweight
Cambridge University Hospitals NHS Foundation Trust 60
Testing effectiveness (Phase 2)Study completedNCT06640972
What this trial is testing

Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists

Who this might be right for
TriglyceridesWeight Gain TrajectoryCholesterol, Elevated
Response Pharmaceuticals 68
Testing effectiveness (Phase 2)Looking for participantsNCT07046819
What this trial is testing

Tirzepatide in MetALD

Who this might be right for
Metabolic Alcohol-associated Liver DiseaseAlcohol Use Disorder
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 120
Post-approval studies (Phase 4)Looking for participantsNCT07154719
What this trial is testing

GLP-1R Actions on Muscle and the Skeleton

Who this might be right for
Musculoskeletal AbnormalitiesObesitySarcopenic Obesity+2 more
Pennington Biomedical Research Center 50
Large-scale testing (Phase 3)Study completedNCT04844918
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity Disease

Who this might be right for
Obesity
Eli Lilly and Company 267
Post-approval studies (Phase 4)Looking for participantsNCT06864026
What this trial is testing

Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Who this might be right for
Psoriatic ArthritisOverweight or Obesity
Eli Lilly and Company 200
Early research (Phase 1)Study completedNCT06916065
What this trial is testing

Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity

Who this might be right for
OverweightObesity
Eli Lilly and Company 188
Not applicableLooking for participantsNCT07373834
What this trial is testing

Tirzepatide and Muscle Outcomes in Obesity

Who this might be right for
Obesity (Disorder)
University Medical Centre Ljubljana 30
Testing effectiveness (Phase 2)Looking for participantsNCT06651177
What this trial is testing

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Who this might be right for
Opioid Use DisorderOpioid Use Disorder, ModerateOpioid Use Disorder, Severe
T. John Winhusen, PhD 310
Testing effectiveness (Phase 2)Active Not RecruitingNCT06643728
What this trial is testing

Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 240
Early research (Phase 1)Study completedNCT03482024
What this trial is testing

Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Who this might be right for
Renal InsufficiencyEnd Stage Renal Disease
Eli Lilly and Company 45
Post-approval studies (Phase 4)Looking for participantsNCT07423247
What this trial is testing

Tirzepatide (Spartina) in Obese Kidney Transplant Recipients

Who this might be right for
Tirzepatide
Shahid Beheshti University of Medical Sciences 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078838
What this trial is testing

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Intraepithelial NeoplasiaGrade 1 Endometrial Endometrioid Carcinoma
UNC Lineberger Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT03954834
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 478
Large-scale testing (Phase 3)Active Not RecruitingNCT06918405
What this trial is testing

Efficacy and Safety of Tirzepatide for Weight Management

Who this might be right for
Obesity and Obesity-related Medical Conditions
Chittagong Medical College 440
Testing effectiveness (Phase 2)Active Not RecruitingNCT06893211
What this trial is testing

Effect of Tirzepatide on Brown Adipose Tissue in Obesity

Who this might be right for
Obesity
University Medical Centre Ljubljana 35
Large-scale testing (Phase 3)Active Not RecruitingNCT06075667
What this trial is testing

Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
Eli Lilly and Company 150
Early research (Phase 1)Study completedNCT03322631
What this trial is testing

Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 48
Large-scale testing (Phase 3)Study completedNCT05260021
What this trial is testing

Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Who this might be right for
Type2 DiabetesDiabetes MellitusDiabetes Mellitus, Type 2+5 more
Eli Lilly and Company 99
Not applicableNot Yet RecruitingNCT06885736
What this trial is testing

LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy

Who this might be right for
Obesity
Dasman Diabetes Institute 232
Load More Results